🇺🇸 FDA
Pipeline program

DOCETAXEL , AVELUMAB, FLUOROURACIL , OXALIPLATIN , CALCIUM FOLINATE

VHIO19001

Phase 2 small_molecule active

Quick answer

DOCETAXEL , AVELUMAB, FLUOROURACIL , OXALIPLATIN , CALCIUM FOLINATE for Resectable Gastric cancer (GC) or Gastroesophageal Junction cancer (GEJC) is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Resectable Gastric cancer (GC) or Gastroesophageal Junction cancer (GEJC)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials